Mondrian Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$100M |
| 2 |
Banco Santander
SAN
|
+$94.6M |
| 3 |
Sony
SONY
|
+$84.2M |
| 4 |
BP
BP
|
+$80.4M |
| 5 |
Autoliv
ALV
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$83.3M |
| 2 |
S&P Global
SPGI
|
+$76M |
| 3 |
Amazon
AMZN
|
+$57M |
| 4 |
Petrobras
PBR
|
+$27.7M |
| 5 |
Centene
CNC
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.27% |
| 2 | Technology | 14.96% |
| 3 | Financials | 14.7% |
| 4 | Energy | 14.06% |
| 5 | Communication Services | 8.05% |
Similar funds
Mondrian Investment Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Mondrian Investment Partners held 103 positions worth $6.33B, up 30% from $4.86B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Mondrian Investment Partners deployed $1.12B of net new capital in Q4 2023, opening 12 new positions and adding to 39 existing holdings. Its largest new stake was UnitedHealth: 188,420 shares worth $99.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was S&P Global, an estimated $76M trimmed.
- Mondrian Investment Partners's largest Q4 2023 buy was UnitedHealth: 188,420 shares worth $99.2M.
- Mondrian Investment Partners added most to Banco Santander in Q4 2023, an estimated $94.6M increase.
- Mondrian Investment Partners's biggest Q4 2023 reduction was S&P Global, cutting an estimated $76M.
- Mondrian Investment Partners fully exited Dell in Q4 2023, selling an estimated $83.3M.
- Mondrian Investment Partners's ten largest holdings make up 33% of its $6.33B portfolio in Q4 2023.
- Mondrian Investment Partners opened 12 new positions and closed 5 in Q4 2023.
- Mondrian Investment Partners's portfolio value rose 30% quarter-over-quarter to $6.33B.
Based on Mondrian Investment Partners's 13F filing for Q4 2023, filed 13 Feb 2024.